Lenalidomide Maintenance Improves Survival in Poor Prognosis DLBCL

Lenalidomide maintenance significantly improves survival in patients with relapsed diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplantation (ASCT).
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Conferences/ASH 2016 Leukemia & Lymphoma News Source Type: news